Bayern Munich is actively evaluating the possibility of selling Jamal Musiala, driven by persistent concerns that his recent health issues may permanently hinder his return to peak form. The 23-year-old Germany international suffered two on-pitch collapses during pre-season friendlies against Heidenheim and RB Leipzig, leading to a diagnosis of “neurological dysfunction.” While Musiala has publicly expressed optimism, stating there is “no additional health risk beyond this,” the club’s internal assessment suggests a more cautious approach regarding his long-term reliability.
Rummenigge questions salary justification as ‘neurological dysfunction’ clouds star’s future
The situation has escalated with Bayern chief Karl-Heinz Rummenigge admitting that the club is rigorously assessing the midfielder’s future amid a noticeable downturn in performance metrics. Rummenigge has publicly questioned whether the club can continue to justify Musiala’s lofty salary package, signaling a potential shift in the club’s financial strategy. This scrutiny marks a significant turning point for a player who was once viewed as an untouchable cornerstone of the Bavarian giant’s midfield, now facing pressure to prove his worth beyond his market value.
For Bayern Munich, the decision to potentially offload Musiala represents a complex balancing act between financial prudence and sporting ambition. If the club proceeds with a sale, it could trigger a significant transfer market ripple effect, with top-tier European clubs likely to monitor the situation closely for an opportunity to acquire a high-profile talent at a potentially reduced valuation. Conversely, retaining Musiala requires a substantial investment in medical support and performance recovery, with the club betting that his underlying talent will overcome the physical setbacks that have defined his recent months.
Source: The Independent Sport



